Williams' Eight-Month Mission: Research Highlights and Spacewalks

NASA astronaut Chris Williams is preparing to return to Earth after an eight-month stay on the International Space Station, his first mission. Throughout his time in orbit, Williams contributed to a broad range of experiments aimed at improving life on Earth and enabling future deep-space exploration.

One significant effort involved processing DNA-inspired materials that could lead to targeted cancer treatments. In microgravity, these rod-shaped structures form more uniformly, potentially enhancing their ability to penetrate solid tumours and deliver medicine in a controlled manner. Williams also worked on growing protein crystals for a new oral cancer therapy and helped investigate the use of ultraviolet light to prevent biofilm formation—a sanitation method that could reduce the need for chemical disinfectants on long-duration missions.

On the technology front, Williams conducted semiconductor crystal growth experiments. Space-grown crystals have historically shown improved quality and size, which may boost the performance of high-end computers, artificial intelligence systems, and medical devices. His research lays the groundwork for commercial semiconductor manufacturing in orbit. Additionally, two spacewalks saw him repair the Canadarm2 robotic arm and prepare the station for the final set of Roll Out Solar Arrays, which will increase power generation by about 30% once installed.

Williams also assisted in the capture of Northrop Grumman’s Cygnus XL cargo spacecraft, which delivered 11,000 pounds of supplies, and participated in studies on how microgravity affects human physiology and delicate robotic operations—data that will be critical for the planned Moon and Mars missions.

What the Mission Means for Earth-Based Industries

While the mission is a standard crew rotation, the breadth of research Williams supported carries concrete implications for two industries that rarely intersect: oncology and semiconductor manufacturing.

Path to In-Space Semiconductor Fabrication

Growing semiconductor crystals in microgravity removes the defect-inducing effects of gravity, yielding more uniform and larger crystals than what can be produced on Earth. Previous missions have demonstrated that space-grown crystals can offer performance improvements for advanced computing and AI. This mission pushed the effort closer to commercial viability, with NASA actively positioning the ISS as a testbed for private production. While no commercial contracts have been announced, the consistent data stream strengthens the business case for on-orbit manufacturing, a sector that companies like Axiom Space and others are monitoring closely.

Advancing Targeted Cancer Therapies

Williams’ work on DNA-inspired nanostructures and protein crystal growth aims to solve a persistent medical challenge: delivering drugs only to cancer cells, reducing systemic side effects. The uniform formation of these delivery vehicles in space could accelerate the development of oral therapeutics that reach deep into solid tumours. Pharmaceutical R&D on the ISS has already led to improved formulations, and this mission’s results may soon feed into clinical pipelines, offering a competitive edge to drugmakers willing to invest in space-based research.

Infrastructure and the Lunar Gateway

The spacewalks and solar array upgrades are not just routine maintenance. The 30% power boost directly supports expanded research capacity, while the robotic arm repairs and microgravity robotic tests feed design requirements for the planned Lunar Gateway station. As NASA and its partners prioritize long-duration missions, every repair and test becomes a blueprint for autonomous systems that will operate beyond low Earth orbit.